CompletedPhase 1/2

Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis

Vietnam22 participantsStarted 2014-06-16

Plain-language summary

To evaluate the safety and efficacy of autologous bone marrow-derived mononuclear cell transplantation in-patient with neurological sequelae due to encephalitis or meningitis

Who can participate

Age range2 Years – 15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Neurological sequelae due to encephalitis or meningitis Exclusion Criteria: * Coagulation disorders * Allergy to anesthetic agents * Severe health conditions such as cancer, failure of heart, lung, liver or kidney * Active infections

What they're measuring

Change in Total Score of Gross Motor Function Measure (GMFM-88)

Timeframe: Baseline, 6 months, and 12 months after transplantation

Change in Muscle Tone Assessed by Modified Ashworth Scale (MAS)

Timeframe: Baseline, 6 months, and 12 months after transplantation

Trial details

NCT IDNCT04080921

SponsorVinmec Research Institute of Stem Cell and Gene Technology

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-30

View on ClinicalTrials.gov More Encephalitis trials